Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats

by Marcelo D.M. Cezar, Ricardo L. Damatto, Luana U. Pagan, Aline R.R. Lima, Paula F. Martinez, Camila Bonomo, Camila M. Rosa, Dijon H.S. Campos, Antonio C. Cicogna, Mariana J. Gomes, Silvio A. Oliveira-Jr, Daniella A. Blotta, Marina P. Okoshi, Katashi Okoshi
Published 2015-07-01